Drug Type Biological products |
Synonyms M-004 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Greenfire Bio LLCStartup |
Active Organization MGFB BioGreenfire Bio LLCStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | US | 30 Nov 2022 | |
Hepatocellular Carcinoma | Preclinical | US | Greenfire Bio LLCStartup | 30 Nov 2022 |